Atlas Trials

Efficacy and Safety of Lenalidomide Plus CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma

Clinical trial NCT04922567 · RECRUITING

Trial details

NCT number
NCT04922567
Sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Peripheral T-Cell LymphomaLenalidomideCHOP
Start date
2021-04-01
Primary completion
2023-12-31
Enrollment
289

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.